EMA begins review of GSK/Vir’s COVID-19 antibody
16th April 2021 Uncategorised 0The review will include an interim analysis of efficacy and safety data from the Phase III COMET-ICE trial More: EMA begins review of GSK/Vir’s COVID-19 antibody Source: News
read more